| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Brimonidine |
| Brand | Mirvaso® |
| Indication | Treatment of facial erythema of rosacea in adult patients. |
| Assessment Process | |
| Rapid review commissioned | 09/04/2014 |
| Rapid review completed | 06/05/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |